Significant association of Caveolin-1 genotypes with bladder cancer susceptibility in Taiwan

Chinese Journal of Physiology

Volumn 54, Issue 3, 2011, Pages 2-

  Bau, Da Tian ^a,b,d   Chang, Chao Hsiang ^a   Tsai, Ru Yin ^a   Wang, Hwei Chung ^a   Wang, Rou Fen ^a   Tsai, Chia Wen ^a,b   Yao, Chun Hsu ^c   Chen, Yueh Sheng ^c   Shyue, Song Kun ^d   Huang, Chih Yang ^b,e  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c Department of Biomedical Imaging and Radiological Science ^*  (Taiwan)

^d INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^e ASIA UNIVERSITY   (Taiwan)

Author keywords

Bladder cancer; Carcinogenesis; Caveolin 1; Polymorphism

Indexed keywords

CAVEOLIN 1; TUMOR MARKER;

ADULT; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MALE; POPULATION BASED CASE CONTROL STUDY; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING HABIT; TAIWAN; ALLELE; ASIAN; BLADDER TUMOR; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PATHOLOGY; RISK FACTOR;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CAVEOLIN 1; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TAIWAN; URINARY BLADDER NEOPLASMS;

EID: 79954475592     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: 10.4077/CJP.2011.AMM009     Document Type: Article

References (33)

1. Bau, D.T., Tsai, M.H., Huang, C.Y., Lee, C.C., Tseng, H.C., Lo, Y.L., Tsai, Y. and Tsai, F.J. Relationship between polymorphisms of nucleotide excision repair genes and oral cancer risk in Taiwan: evidence for modification of smoking habit. Chinese J. Physiol. 50: 294-300, 2007.
2. Bau, D.T., Wang, H.C., Liu, C.S., Chang, C.L., Chiang, S.Y., Wang, R.F., Tsai, C.W., Lo, Y.L., Hsiung, C.A., Lin, C.C. and Huang, C.Y. Single-nucleotide polymorphism of the Exo1 gene: association with gastric cancer susceptibility and interaction with smoking in Taiwan. Chinese J. Physiol. 52: 411-418, 2009.
3. Belanger, M.M., Roussel, E. and Couet, J. Caveolin-1 is downregulated in human lung carcinoma and acts as a candidate tumor suppressor gene. Chest 125: 106S, 2004.
4. Carver, L.A., Schnitzer, J.E., Anderson, R.G. and Mohla, S. Role of caveolae and lipid rafts in cancer: workshop summary and future needs. Cancer Res. 63: 6571-6574, 2003.
5. Chan, T.F., Su, T.H., Yeh, K.T., Chang, J.Y., Lin, T.H., Chen, J.C., Yuang, S.S. and Chang, J.G. Mutational, epigenetic and expressional analyses of caveolin-1 gene in cervical cancers. Int. J. Oncol. 23: 599-604, 2003.
6. Chang, C.H., Wang, R.F., Tsai, R.Y., Wu, H.C., Wang, C.H., Tsai, C.W., Chang, C.L., Tsou, Y.A., Liu, C.S. and Bau, D.T. Significant association of XPD codon 312 single nucleotide polymorphism with bladder cancer susceptibility in Taiwan. Anticancer Res. 29: 3903-3907, 2009.
7. Chen, S.T., Lin, S.Y., Yeh, K.T., Kuo, S.J., Chan, W.L., Chu, Y.P. and Chang, J.G. Mutational, epigenetic and expressional analyses of caveolin-1 gene in breast cancers. Int. J. Mol. Med. 14: 577-582, 2004.
8. Cohen, S.M., Shirai, T. and Steineck, G. Epidemiology and etiology of premalignant and malignant urothelial changes. Scand. J. Urol. Nephrol. 205: 105-115, 2000.
9. Conde, M.C., Ramirez-Lorca, R., Lopez-Jamar, J.M., Molero, E., Ramirez-Armengol, J.A., Moreno Nogueira, J.A., Pascual, M.H., Ruiz, A., Martin-Cordova, C.G., Real, L.M. and Royo, J.L. Genetic analysis of caveolin-1 and eNOS genes in colorectal cancer. Oncol. Rep. 16: 353-359, 2006.
10. del Pozo, M.A., Balasubramanian, N., Alderson, N.B., Kiosses, W.B., Grande-Garcia, A., Anderson, R.G. and Schwartz, M.A. Phospho-caveolin-1 mediates integrin-regulated membrane domain internalization. Nat. Cell Biol. 7: 901-908, 2005.
11. Engelman, J.A., Zhang, X.L., Razani, B., Pestell, R.G. and Lisanti, M.P. p42/44 MAP kinase-dependent and -independent signaling pathways regulate caveolin-1 gene expression. Activation of Ras- MAP kinase and protein kinase a signaling cascades transcriptionally down-regulates caveolin-1 promoter activity. J. Biol. Chem. 274: 32333-32341, 1999.
12. Franekova, M., Halasova, E., Bukovska, E., Luptak, J. and Dobrota, D. Gene polymorphisms in bladder cancer. Urol. Oncol. 26: 1-8, 2008.
13. Galbiati, F., Engelman, J.A., Volonte, D., Zhang, X.L., Minetti, C., Li, M., Hou, H., Jr., Kneitz B., Edelmann, W. and Lisanti, M.P. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities. J. Biol. Chem. 276: 21425-21433, 2001.
14. Haeusler, J., Hoegel, J., Bachmann, N., Herkommer, K., Paiss, T., Vogel, W. and Maier, C. Association of a CAV-1 haplotype to familial aggressive prostate cancer. Prostate 65: 171-177, 2005.
15. Han, S.E., Park, K.H., Lee, G., Huh, Y.J. and Min, B.M. Mutation and aberrant expression of Caveolin-1 in human oral squamous cell carcinomas and oral cancer cell lines. Int. J. Oncol. 24: 435- 440, 2004.
16. Hayashi, K., Matsuda, S., Machida, K., Yamamoto, T., Fukuda, Y., Nimura, Y., Hayakawa, T. and Hamaguchi, M. Invasion activating caveolin-1 mutation in human scirrhous breast cancers. Cancer Res. 61: 2361-2364, 2001.
17. Heshmati, Y., Mirabzadeh, A., Feizzade, G., Gilanipour, M., Etminan, M.R., Khoram Khorshid, H.R., Kamali, K., Fakhri, M., Moghimi, N., Najmabadi, H. and Ohadi, M. A novel polymorphic purine complex at the 1.5 kb upstream region of the human caveolin- 1 gene and risk of Alzheimer's disease; extra-short alleles and accumulated allele homozygosity. Am. J. Med. Genet B Neuropsychiatr. Genet 150B: 248-253, 2009.
18. Juhasz, M., Chen, J., Tulassay, Z., Malfertheiner, P. and Ebert, M.P. Expression of caveolin-1 in gastrointestinal and extraintestinal cancers. J. Cancer Res. Clin. Oncol. 129: 493-497, 2003.
19. Kato, K., Hida, Y., Miyamoto, M., Hashida, H., Shinohara, T., Itoh, T., Okushiba, S., Kondo, S. and Katoh, H. Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Cancer 94: 929-933, 2002.
20. Lee, S.W., Reimer, C.L., Oh, P., Campbell, D.B. and Schnitzer, J.E. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene 16: 1391-1397, 1998.
21. Li, T., Sotgia, F., Vuolo, M.A., Li, M., Yang, W.C., Pestell, R.G., Sparano, J.A. and Lisanti, M.P. Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alphapositive status. Am. J. Pathol. 168: 1998-2013, 2006.
22. Moore, J., McKnight, A.J., Simmonds, M.J., Courtney, A.E., Hanvesakul, R., Brand, O.J., Briggs, D., Ball, S., Cockwell, P., Patterson, C.C., Maxwell, A.P., Gough, S.C. and Borrows, R. Association of caveolin-1 gene polymorphism with kidney transplant fibrosis and allograft failure. J. Am. Med. Assoc. 303: 1282- 1287, 2010.
23. Parkin, D.M. International variation. Oncogene 23: 6329-6340, 2004.
24. Rajjayabun, P.H., Garg, S., Durkan, G.C., Charlton, R., Robinson, M.C. and Mellon, J.K. Caveolin-1 expression is associated with high-grade bladder cancer. Urology 58: 811-814, 2001.
25. Sawada, S., Ishikawa, C., Tanji, H., Nakachi, S., Senba, M., Okudaira, T., Uchihara, J.N., Taira, N., Ohshiro, K., Yamada, Y., Tanaka, Y., Uezato, H., Ohshima, K., Sasai, K., Burgering, B.M., Duc Dodon, M., Fujii, M., Sunakawa, H. and Mori, N. Overexpression of caveolin-1 in adult T-cell leukemia. Blood 115: 2220- 2230, 2010.
26. Smart, E.J., Graf, G.A., McNiven, M.A., Sessa, W.C., Engelman, J.A., Scherer, P.E., Okamoto, T. and Lisanti, M.P. Caveolins, liquid-ordered domains, and signal transduction. Mol. Cell Biol. 19: 7289-7304, 1999.
27. Steineck, G., Wiholm, B.E. and Gerhardsson de Verdier, M. Acetaminophen, some other drugs, some diseases and the risk of transitional cell carcinoma. A population-based case-control study. Acta. Oncol. 34: 741-748, 1995.
28. Wang, Y.H., Lee, Y.H., Tseng, P.T., Shen, C.H. and Chiou, H.Y. Human NAD(P)H: quinone oxidoreductase 1 (NQO1) and sulfotransferase 1A1 (SULT1A1) polymorphisms and urothelial cancer risk in Taiwan. J. Cancer Res. Clin. Oncol. 134: 203-209, 2008.
29. Wiechen, K., Diatchenko, L., Agoulnik, A., Scharff, K.M., Schober, H., Arlt, K., Zhumabayeva, B., Siebert, P.D., Dietel, M., Schafer, R. and Sers, C. Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. Am. J. Pathol. 159: 1635-1643, 2001.
30. Wiechen, K., Sers, C., Agoulnik, A., Arlt, K., Dietel, M., Schlag, P.M. and Schneider, U. Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas. Am. J. Pathol. 158: 833-839, 2001.
31. Williams, T.M., Medina, F., Badano, I., Hazan, R.B., Hutchinson, J., Muller, W.J., Chopra, N.G., Scherer, P.E., Pestell, R.G. and Lisanti, M.P. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. J. Biol. Chem. 279: 51630-51646, 2004.
32. Yang, G., Truong, L.D., Wheeler, T.M. and Thompson, T.C. Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker. Cancer Res. 59: 5719-5723, 1999.
33. Yang, M.D., Hsu, Y.M., Kuo, Y.S., Chen, H.S., Chang, C.L., Wu, C.N., Chang, C.H., Liao, Y.M., Wang, H.C., Wang, M.F. and Bau, D.T. Significant association of Ku80 single nucleotide polymorphisms with colorectal cancer susceptibility in Central Taiwan. Anticancer Res. 29: 2239-2242, 2009.